Ori Kalid

1.7k total citations
16 papers, 690 citations indexed

About

Ori Kalid is a scholar working on Molecular Biology, Organic Chemistry and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ori Kalid has authored 16 papers receiving a total of 690 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Organic Chemistry and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ori Kalid's work include Click Chemistry and Applications (4 papers), Computational Drug Discovery Methods (4 papers) and Chemical Synthesis and Analysis (3 papers). Ori Kalid is often cited by papers focused on Click Chemistry and Applications (4 papers), Computational Drug Discovery Methods (4 papers) and Chemical Synthesis and Analysis (3 papers). Ori Kalid collaborates with scholars based in United States, Israel and Germany. Ori Kalid's co-authors include Dora Toledo Warshaviak, Sharon Shacham, Yael Marantz, G. Golan, Kai Zhu, Kenneth Borrelli, Nir Ben‐Tal, Merav Fichman, Boaz Inbal and Alexander Heifetz and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Ori Kalid

15 papers receiving 675 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ori Kalid United States	12	513	194	150	101	90	16	690
Stuart P. McElroy United Kingdom	17	462 0.9×	65 0.3×	46 0.3×	136 1.3×	45 0.5×	32	789
Matthis Geitmann Sweden	16	507 1.0×	77 0.4×	25 0.2×	134 1.3×	71 0.8×	29	742
Ambuj Kumar India	16	627 1.2×	101 0.5×	41 0.3×	50 0.5×	18 0.2×	37	840
Heejun Hwang South Korea	7	462 0.9×	42 0.2×	56 0.4×	45 0.4×	27 0.3×	9	649
Jianghong An Canada	13	865 1.7×	323 1.7×	20 0.1×	67 0.7×	28 0.3×	20	1.1k
Thorsten Jumpertz Germany	12	422 0.8×	65 0.3×	39 0.3×	50 0.5×	37 0.4×	17	861
Dan Zhou China	15	512 1.0×	74 0.4×	26 0.2×	31 0.3×	31 0.3×	30	1.1k
Ireos Filipuzzi Switzerland	13	687 1.3×	67 0.3×	13 0.1×	63 0.6×	70 0.8×	21	897
Robert R. Lavieri United States	11	440 0.9×	55 0.3×	18 0.1×	63 0.6×	36 0.4×	17	685
Marlet Martínez‐Archundia Mexico	13	335 0.7×	123 0.6×	16 0.1×	68 0.7×	36 0.4×	39	542

Countries citing papers authored by Ori Kalid

Since Specialization

Citations

This map shows the geographic impact of Ori Kalid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ori Kalid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ori Kalid more than expected).

Fields of papers citing papers by Ori Kalid

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ori Kalid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ori Kalid. The network helps show where Ori Kalid may publish in the future.

Co-authorship network of co-authors of Ori Kalid

This figure shows the co-authorship network connecting the top 25 collaborators of Ori Kalid. A scholar is included among the top collaborators of Ori Kalid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ori Kalid. Ori Kalid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Kalid, Ori, et al.. (2022). PTX80, a novel compound targeting the autophagy receptor p62/SQSTM1 for treatment of cancer. Chemical Biology & Drug Design. 100(5). 623–638. 4 indexed citations

Shitrit, Alina, Daniel Zaidman, Ori Kalid, et al.. (2020). Conserved interactions required for inhibition of the main protease of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Scientific Reports. 10(1). 20808–20808. 45 indexed citations

Crochiere, Marsha, Trinayan Kashyap, Ori Kalid, et al.. (2015). Deciphering mechanisms of drug sensitivity and resistance to Selective Inhibitor of Nuclear Export (SINE) compounds. BMC Cancer. 15(1). 910–910. 23 indexed citations

Warshaviak, Dora Toledo, G. Golan, Kenneth Borrelli, Kai Zhu, & Ori Kalid. (2014). Structure-Based Virtual Screening Approach for Discovery of Covalently Bound Ligands. Journal of Chemical Information and Modeling. 54(7). 1941–1950. 114 indexed citations

Machlus, Kellie R., Stephen Wu, Robert Carlson, et al.. (2014). Selinexor-Induced Thrombocytopenia Results from the Inhibition of Megakaryocyte Progenitor Cells in the Early Stage of Megakaryopoiesis. Blood. 124(21). 1458–1458.

Azmi, Asfar S., William Senapedis, Erkan Baloglu, et al.. (2014). Novel PAK4 inhibitors for pancreatic cancer therapy.. Journal of Clinical Oncology. 32(3_suppl). 233–233. 1 indexed citations

Senapedis, William, Marsha Crochiere, Tami Rashal, et al.. (2013). Abstract B198: Selinexor (KPT-330), a novel Selective Inhibitor of Nuclear Export (SINE) shows marked NF-kB inhibition and significant anticancer activity against Non-Small Cell Lung Cancer (NSCLC).. Molecular Cancer Therapeutics. 12(11_Supplement). B198–B198. 1 indexed citations

Kalid, Ori, Dora Toledo Warshaviak, Sharon Shechter, Woody Sherman, & Sharon Shacham. (2012). Consensus Induced Fit Docking (cIFD): methodology, validation, and application to the discovery of novel Crm1 inhibitors. Journal of Computer-Aided Molecular Design. 26(11). 1217–1228. 62 indexed citations

Hudson, Rhea P., P. Andrew Chong, Irina I. Protasevich, et al.. (2012). Conformational Changes Relevant to Channel Activity and Folding within the first Nucleotide Binding Domain of the Cystic Fibrosis Transmembrane Conductance Regulator. Journal of Biological Chemistry. 287(34). 28480–28494. 42 indexed citations

10.

Dalton, James A. R., Ori Kalid, Maya Schushan, Nir Ben‐Tal, & Jordi Villà‐Freixa. (2012). New Model of Cystic Fibrosis Transmembrane Conductance Regulator Proposes Active Channel-like Conformation. Journal of Chemical Information and Modeling. 52(7). 1842–1853. 64 indexed citations

11.

Kalid, Ori, Martin Mense, Sharon Fischman, et al.. (2010). Small molecule correctors of F508del-CFTR discovered by structure-based virtual screening. Journal of Computer-Aided Molecular Design. 24(12). 971–991. 73 indexed citations

12.

Sela, Itamar, G. Golan, Dalia Rivenzon‐Segal, et al.. (2010). G Protein Coupled Receptors - In Silico Drug Discovery and Design. Current Topics in Medicinal Chemistry. 10(6). 638–656. 24 indexed citations

13.

Haas, Michael, et al.. (2010). 5-OMe-UDP is a Potent and Selective P2Y₆-Receptor Agonist. Journal of Medicinal Chemistry. 53(4). 1673–1685. 29 indexed citations

14.

Kalid, Ori & Nir Ben‐Tal. (2009). Study of MDM2 Binding to p53-Analogues: Affinity, Helicity, and Applicability to Drug Design. Journal of Chemical Information and Modeling. 49(4). 865–876. 14 indexed citations

15.

Becker, Oren M., Yael Marantz, Sharon Shacham, et al.. (2004). G protein-coupled receptors: In silico drug discovery in 3D. Proceedings of the National Academy of Sciences. 101(31). 11304–11309. 110 indexed citations

16.

Shacham, Sharon, Yael Marantz, Ori Kalid, et al.. (2004). PREDICT modeling and in‐silico screening for G‐protein coupled receptors. Proteins Structure Function and Bioinformatics. 57(1). 51–86. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact